Best Life Sciences Platforms and Tools Companies in Netherlands
The 184 best Life Sciences Platforms and Tools companies in Netherlands in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: LUMICKS.
Ranking the best Life Sciences Platforms and Tools companies in Netherlands by disclosed equity funding and recent momentum, this directory tracks 184 companies with a combined $423M in disclosed capital. That number tells you something real about the sector's depth here. The global market sat at $89.4B in 2020 and is forecast to reach $183.8B by 2027 at a 10.8% CAGR, driven by advances in quantitative accuracy, MS resolution, and information sciences. Two names dominate the funding picture: Lumicks has pulled in $93M and Ncardia $77M, together accounting for roughly 40% of all disclosed funding in this cohort. The rest of the field is fragmented, with most players sitting well under $10M raised.
So what's the actual texture of this market? I'd call it a high-potential, early-stage ecosystem. Investors like EIC Fund, Oost NL, and Brightlands Venture Partners are active, but the zero-unicorn count signals that big exits haven't materialized yet. Regulatory challenges remain a structural headwind that keeps capital cautious. Demand drivers are real and compounding, though, and the concentration of institutional backing in a handful of companies suggests the next wave of growth will likely consolidate around platforms with defensible technology, exactly where you'd expect Lumicks-style deep-tech bets to pay off.
- ResearchAndMarkets.com
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Netherlands
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LUMICKS Manufacturer of optical tweezers for single molecule analysis instruments | $93M | 20 mo ago | 263 | 2014 | Andrea Candelli Co-Founder | Webflow EcommerceWebflowMemberStack+25 | — | 1 launch |
| 2 | Ncardia Company offering hiPSC based products and services for drug discovery and development | $77M | 55 mo ago | 79 | 2011 | Stefan Braam Co-Founder & President | HubSpot CMS Hubcore-jsjQuery+12 | 35 patents Manufacturing and differentiation of pluripotent stem cell-derived cardiomyocytes for therapeutic use. | 1 launch |
| 3 | Esperite Cord blood Bank | $49M | 70 mo ago | 72 | 2000 | — | — | — | — |
| 4 | Mimetas Develops microfluidics-based organ-on-a-chip tissue models | $29M | 45 mo ago | 108 | 2013 | Paul Vulto Co-Founder & Co-CEO | Webflowcore-jsjQuery+12 | 86 patents Microfluidic organ-on-a-chip platforms for 3D tissue and vascular modeling | 1 launch |
| 5 | Xpand Biotechnology Developer of alternative bio-reactors for 2D cell culture | $17M | 107 mo ago | 15 | 2004 | Joost De Bruijn Founder | — | 19 patents Single-use bioreactors with pH/gas control and osteoinductive calcium‑phosphate biomaterials | — |
| 6 | Amarna Therapeutics Developer of immune-modulating gene therapies for rare and prevalent autoimmune diseases and genetic diseases | $11M | 80 mo ago | 30 | 2008 | Marjanne Messie CFO | CMS Made SimplePleskPHP+15 | 5 patents Patents concentrated in chemistry & materials | — |
| 7 | Photanol Provider of technology for light-powered bio-production of chemicals | $9M | 54 mo ago | 39 | 2008 | — | — | 27 patents Photosynthetic microbial synthesis of platform chemicals (propylene, glycolate, 1,3‑propanediol, erythritol). | — |
| 8 | Pepscan Pepscan employs protein mimicry techniques for the R&D of therapeutic drugs and a range of specialty peptide… | $9M | 41 mo ago | 45 | 2000 | — | — | — | 1 partnership |
| 9 | ProteoNic Provider of products and services for improving recombinant protein production levels | $8M | 176 mo ago | 20 | 2007 | Frank Pieper CEO | WordPressMySQLPHP+23 | — | — |
| 10 | Malvern Panalytical R&D company focused on manufacturing of medical instruments for multiple industries | $7M | 56 mo ago | 1,771 | 2017 | — | Apple iCloud MailMicrosoft 365YouTube+22 | 136 patents X-ray fluorescence and diffraction instrumentation for high‑resolution material analysis | — |
| 11 | Polyganics Bioresorbable medical devices for regenerative medicine | $7M | 73 mo ago | 75 | 1999 | — | — | 122 patents Patents concentrated in health & consumer products | — |
| 12 | Micronit Microfluidic design and manufacturing | $6M | 29 mo ago | 13 | 1999 | — | Cart FunctionalityMagentoMySQL+17 | — | 3 job openings |
| 13 | Hudson River Biotechnology Developer of DNA-free CRISPR technology for crop resilience and yield improvement | $6M | 26 mo ago | 30 | 2015 | — | — | 4 patents Encapsulation particles for delivering hydrophilic/amphiphilic bio‑compounds | — |
| 14 | CytoSMART Provider of an AI-based cell- imaging analysis software and hardware solution | $6M | 86 mo ago | 58 | 2012 | Jan Willem Van Bree Co-Founder | — | — | — |
| 15 | Confocal Developer of improved confocal microscope | $6M | 20 mo ago | 16 | 2016 | Pim Vos CEO | — | 11 patents Advanced re-scan optical systems for high‑precision confocal microscopy imaging | — |
| 16 | EnzyPep Develops peptide synthesis technology | $6M | 127 mo ago | 6 | 2012 | Peter van Tilburg CEO | — | 48 patents Engineered thermostable enzymes for peptide drug synthesis and lactulose bioproduction | — |
| 17 | Pepscope Provider of services for proteomics using microarray and mass spectrometry | $5M | 66 mo ago | — | 2012 | Jos Joore Co-Founder & CEO | — | — | — |
| 18 | Iamfluidics Provider of in-air microfluidics technology for research | $5M | 44 mo ago | 32 | 2018 | — | UmbracoCart FunctionalityEcwid+11 | — | — |
| 19 | EV Biotech Developer of biological productions of biomaterials | $5M | 38 mo ago | 30 | 2018 | Linda Dijkshoorn CEO and founder | WordPressMySQLPHP+21 | — | — |
| 20 | Delmic B.V. Provider of light and electron microscopy solutions for life sciences and materials science | $4M | 38 mo ago | 50 | 2011 | Sander Hoedt CEO | HubSpot CMS HubRequireJSLazySizes+19 | 88 patents Focused ion beam micromachining and multi-beam charged‑particle sample inspection systems | — |
| 21 | BIOND Solutions Developer of organ-on-chip platform for cell-based assays | $4M | 51 mo ago | 13 | 2016 | — | WordPressMySQLPHP+28 | 16 patents Integrated microfluidic chambers for 3D muscle tissue engineering and organ‑on‑chip platforms | — |
| 22 | Optics11 Life Online e-distributor offering scientific equipment | $4M | 8 mo ago | 55 | 2011 | Davide Iannuzzi Co-Founder | Cart FunctionalityWordPressMySQL+31 | — | — |
| 23 | Scinus Developer of closed-system bioreactors for cell therapy production | $3M | 3 mo ago | 8 | 2016 | — | — | — | 1 internship · 1 partnership |
| 24 | Harbour Antibodies Production of antibodies and VH (heavy chain with one variable) domains for therapy | $3M | 75 mo ago | 10 | 2006 | — | — | 25 patents Therapeutic antibodies and antibody‑nanoparticle conjugates for targeted disease treatment | — |
| 25 | Kreatech Developer of novel FISH probes for detection and quantification | $3M | 198 mo ago | — | 1996 | Kees Moonen CEO | — | — | — |
| 26 | Cergentis Provider of kits and services for the targeted sequencing of genes | $3M | 73 mo ago | 39 | 2012 | — | — | 41 patents 3D genome region sequencing and targeted copy-number heterogeneity analysis | — |
| 27 | FlowView Diagnostics Digital flow cytometry tool for cell analysis | $3M | 47 mo ago | 9 | 2020 | Ton Den Hoven Co-Founder & CEO | — | — | — |
| 28 | MILabs Develops Imaging Instruments for clinical and pre-clinical applications | $3M | 116 mo ago | 48 | 2004 | — | WordPressMySQLPHP+31 | 82 patents Advanced nuclear medical imaging hardware—gamma cameras, SPECT scanners, X‑ray systems, and collimators. | — |
| 29 | Cleara Developer of biomarkers and therapies to treat cancer and aging diseases | $2M | 44 mo ago | 10 | 2017 | Marco Demaria Co-Founder | WordPressMySQLPHP+12 | — | — |
| 30 | Toxys Developer of In vitro genotoxicity testing services | $2M | 75 mo ago | 23 | 2014 | — | WordPressApple iCloud MailMicrosoft 365+42 | 3 patents In vitro embryonic development assays for toxicology and drug safety evaluation. | 2 launchs |
| 31 | Amsterdam Scientific Instruments Leveraging particle physics for innovative imaging applications | $2M | 103 mo ago | 27 | 2011 | — | — | — | 2 launchs |
| 32 | DAB Technology solutions provider for accelerated fermentation | $2M | 7 mo ago | 20 | 2012 | Kirsten Herben-Steinbusch Founder | SanityRadix UITailwind CSS+18 | — | — |
| 33 | Bac Discovers, develops and manufactures separation and affinity purification products | $2M | 212 mo ago | — | 2002 | Amar Patel CEO & President | — | 56 patents Engineered single-domain antibody fragments targeting IgG CH1 for affinity purification | — |
| 34 | River BioMedics Developer of stem-cell-derived organoid models for cardiac drug discovery | $2M | 43 mo ago | 11 | 2018 | Lisanne Blauw COO / Co-founder | — | 3 patents Microfluidic platforms for 3‑dimensional tissue engineering and organ‑on‑chip models | — |
| 35 | Scope Biosciences Developer of CRISPR-Cas based diagnostic platform | $2M | 31 mo ago | 8 | 2019 | Stijn Prinsen Co-Founder | Cart FunctionalitySquarespace CommerceSquarespace+13 | 4 patents Type III CRISPR/Cas molecular diagnostic assays for nucleic acid detection | — |
| 36 | Hycult Biotech Manufacturer of products related to inflammation and cell and tissue damage | $2M | 65 mo ago | — | 1994 | — | WordPress Block EditorWordPressMySQL+33 | 3 patents Predictive diagnostic assays for multisystem inflammatory syndrome risk assessment | — |
| 37 | Materiomics Provider of surface design services for cell culture devices | $1M | 126 mo ago | 8 | 2009 | Jan de Boer Co-Founder & CSO | — | 7 patents Micro‑engineered surface topographies that modulate cell physiology and promote endothelialization. | — |
| 38 | GenomeScan Provider of next-generation genome sequencing and testing | $1M | 43 mo ago | 38 | 2002 | Peter Belt CEO | WordPressMySQLPHP+28 | — | 1 job opening · 1 internship |
| 39 | BaseClear Contract service laboratory with a focus on DNA technology, genomics and synthetic biology. | $1M | 82 mo ago | 96 | 1993 | — | WordPress Block EditorCart FunctionalityWordPress+27 | — | 3 job openings · 4 internships |
| 40 | Aeon Astron Biotech company focusing on development and marketing of biomaterials and regenerative medical technology for… | $937K | 125 mo ago | 44 | 2008 | Michael Lai CEO & Chairman | — | — | — |
| 41 | ViaZym Developer of bioengineered enzymes | $935K | 77 mo ago | — | 2007 | Luuk Langen CEO | — | — | — |
| 42 | Future Diagnostics Manufacturer of in-vitro diagnostic assay | $933K | 113 mo ago | 64 | 1997 | — | WordPressZohoMySQL+41 | 27 patents Immunoassay kits and reagents for measuring free 25‑hydroxy vitamin D in blood. | — |
| 43 | Optisense Biosensors for monitoring contaminants and biochemical substances | $877K | 108 mo ago | — | 2004 | Floris Alkemade Founder & ex-CEO | — | 22 patents Patents concentrated in computing, sensing & instrumentation | — |
| 44 | Innosieve Diagnostics Provider of microbial diagnostic test kits | $769K | 62 mo ago | 3 | 2007 | — | — | 5 patents Microfilter centrifuge tubes for enhanced sample filtration and separation in laboratory diagnostics | — |
| 45 | 20Med Therapeutics Develops RNA-based therapeutics and vaccines for drug delivery | $736K | 36 mo ago | 13 | 2011 | Michiel Lodder CEO | — | 15 patents Patents concentrated in chemistry & materials | — |
| 46 | ZF-Screens Platform for high-throughput screening of pharmaceutical drug candidates against diseases. | $632K | 134 mo ago | — | 2006 | Ron Dirks CEO | — | 3 patents In vivo high-throughput screening platforms for biological assay automation | — |
| 47 | TROPIQ Health Sciences Barcoded live insect screening technology | $464K | 52 mo ago | 15 | 2012 | Koen Dechering Cofounder and VP of business development | — | 16 patents Patents concentrated in health & consumer products | — |
| 48 | DC4U Glycan based technology for immunotherapeutics | $455K | 74 mo ago | 2 | 2006 | Henk Vietor CEO | — | — | — |
| 49 | Imuno Therapeutics Developer of drug discovery and precision therapy platform for oncology | $340K | 55 mo ago | 5 | 2020 | Jan Verhoef Founder | — | — | — |
| 50 | Isobionics Production of a variety of natural fragrances and flavor compounds by fermentation | $333K | 33 mo ago | 35 | 2008 | Toine Janssen Founder & CEO | TypeScriptVideoJSZone.js+10 | 100 patents Microbial biosynthesis and enzymatic oxidation of high-value terpenes and sesquiterpenes. | — |
Top 12 Life Sciences Platforms and Tools companies in Netherlands
#1
Series A · Bilthoven, Utrecht · founded 2016 · 8 employees$3.5Mraised▾
Developer of closed-system bioreactors for cell therapy production. It provides a cost-effective solution for cultivating clinically relevant cell numbers. The bioreactor system supports both research and development and Good Manufacturing Practice (GMP) processes. Utilizing single-use bags, it offers scalability for large-fold cell expansion. The system is adaptable for both adherent and suspension cell types, using a unique rocking platform to ensure optimal culture conditions. Development included extensive biological process development for various cell types, including mesenchymal stromal cells and induced pluripotent stem cells. The company's technology aims to improve cell therapy and regenerative medicine.
- Mar 2026Series A$3.4M
- Feb 2019Grant (prize money)$36.9K
#2
Series D · Amsterdam, North Holland · founded 2014 · 263 employees$93.4Mraised▾
Manufacturer of optical tweezers for single-molecule analysis instruments. The product portfolio of the company includes C-Trap, an integrated system with optical tweezers, a confocal microscope, and a microfluidic system to analyze protein folding, DNA repair, DNA organization, Protein polymer, and filaments. Its product, AFS-acoustic force spectroscopy (a single molecule manipulation system), and u-Flux (an integrated microfluidic system) are used in performing experiments in a laminar flow environment.
- Oct 2024Venture Debt$21.9M
- Jan 2023Grant (prize money)$294.3K
- Sep 2022Grant (prize money)$48.7K
- Apr 2021Series D$93.4M
#3
Series A · Amsterdam, North Holland · founded 2011 · 55 employees$4Mraised▾
Online e-distributor offering scientific equipment. The company offers features like touch & go interface, semi-automated, modular microscopy capabilities, automatic find surface function, and more. The nanoindenters have various applications like drug screening, disease diagnosis, regenerative medicine, and more.
- Oct 2025Series A$4M
- Jan 2019Grant (prize money)$304.4K
- Nov 2016Grant (prize money)$152.5K
#4
Series A · Delft, South Holland · founded 2012 · 20 employees$2.2Mraised▾
DAB is a technology solutions provider for accelerated fermentation. It enables the production of chemicals, materials, and fuel from renewable feedstock. It also provides solutions for fermentations with a water-insoluble product.
- Oct 2025Series A—
- May 2019Series A$2.2M
#5
Series A · Amsterdam, North Holland · founded 2016 · 16 employees$5.7Mraised▾
Developer of improved confocal microscope. The company engages in developing an improved camera-based RCM (re-scanning confocal microscope) that offers high-resolution good signal-to-noise ratio. It has a new super-resolution technique based on standard confocal microscopy extended with an optical (re-scanning) unit that projects the image directly on a CCD-camera, improved lateral resolution (170 nm at 488 nm light), and strongly improved sensitivity,
#6
Series C · The Hague, South Holland · founded 2011 · 79 employees$77.4Mraised▾
Ncardia, formed by the merger of Pluriomics and Axiogenesis in 2017, is a stem-cell based drug discovery and development services provider specializing in offering hiPSC (human induced Pluripotent Stem Cells) based products and services. Both the companies were providers of human cardiovascular stem cell technology, disease modeling and cell-based assay products and services for cardiovascular drug development at the time of the merger. The company also offers its services for cardiovascular and neural safety and efficacy studies. The company has offices in Belgium, the Netherlands, Germany, and the USA. Their product portfolio includes cardiac cells (hiPSC-derived), cardiac fibroblasts, neural cells (includes pan-neuronal cells, astrocytes and peripheral neurons) and cardiac plates (ready-to-use assay plates).
- Nov 2021Series C$60M
- Feb 2020Grant (prize money)$294.7K
- Jan 2020Grant (prize money)$298K
- Dec 2018Grant (prize money)$3.7M
#7
Series A · Wageningen, Gelderland · founded 2015 · 30 employees$5.9Mraised▾
Developer of DNA-free CRISPR technology for crop resilience and yield improvement. The technology optimizes plant breeding to power and protect future crops. It offers a DNA-free CRISPR method that overcomes traditional limitations. The BioMaas platform allows for multi-trait targeting and scalable automation. Products are completed efficiently once the BioMaas platform has been implemented.
- Apr 2024Series A—
- Aug 2021Series A$5.9M
- Mar 2018Seed—
- Dec 2015Grant (prize money)$54.6K
#8
Series B · Leiden, South Holland · founded 2013 · 108 employees$28.9Mraised▾
Mimetas develops organ-on-a-chip tissue models for evaluating drugs, chemicals, and food components. The products OrganoPlates, OrganoReady, OrganoTEER, and OrganoFlow are microfluidics-based culture plates for in-vitro tissue culture. It enables culturing and screening of 3D organ and tissue models, predicting toxic side effects, drug efficacy, and validates customized disease, toxicology, and transport models.
- Sep 2022Grant (prize money)$272.8K
- Aug 2021Grant (prize money)$59K
- Sep 2020Grant (prize money)$2.2M
- Jun 2020Grant (prize money)$66.9K
#9
Funding Raised · Enschede, Overijssel · founded 1999 · 13 employees$6.1Mraised▾
Micronit started with initial focus on miniaturization of devices using micro technology. It then focused on microfluidics for life sciences applications and has grown into a complete lab-on-chip product development partner. It also provides micro machining services through its MEMS division. Micronit has its own clean room manufacturing facilities, which are set up for wafer scale and batch processing of glass and silicon and are thus ideally suited for wafer-based MEMS applications.
- Jan 2024Grant (prize money)$230.3K
- Sep 2021Grant (prize money)$534.5K
- Feb 2021Grant (prize money)$212.3K
- Jan 2021Grant (prize money)$325.7K
#10
Late Stage · Zutphen, Gelderland · founded 2000 · 72 employees$48.8Mraised▾
Esperite provides services in the collection, processing, and storage of human adult stem cells, collected from the umbilical cord blood, and the umbilical cord, at birth. It is the largest stem cell bank in Europe.
- Jul 2020Post IPO$41M
- Mar 2018Post IPO$6.4M
- Jan 2018Post IPO$298.6K
- Mar 2017Post IPO$1.1M
#11
Acquired · Lelystad, Flevoland · founded 2000 · 45 employees$8.9Mraised▾
Pepscan is provider of custom peptide-based products & services, including peptide synthesis, epitope mapping, peptide arrays, and immunology & antibody services. In addition, Pepscan applies its in-depth knowledge of peptides for the discovery of new peptide drugs in collaborative R&D projects. The Pepscan group consists of a number of wholly owned entities under the umbrella of Pepscan Holding NV. All fee-for-service activities using Pepscan technologies are handled by Pepscan Presto BV, whereas R&D activities take place in Pepscan Therapeutics BV
- Jan 2023Grant (prize money)$294.3K
- Sep 2006Series A$8.9M
#12
Series A · Delft, South Holland · founded 2011 · 50 employees$4.3Mraised▾
Provider of light and electron microscopy solutions for life sciences and materials science. The company claims to have developed a platform for integrated fluorescence and electron microscopy and a cathodoluminescence detection system. It also provides an integrated fluorescence and scanning electron microscope.
- Apr 2023Series A$4.3M
- Nov 2019Grant (prize money)$120K
- Sep 2019Grant (prize money)$2.4M
- Jan 2019Grant (prize money)$14.3K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in the Netherlands
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 921 Netherlands-affiliated papers.
- Utrecht University91
- Wageningen University & Research90
- Amsterdam University Medical Centers81
- Erasmus MC75
- Leiden University Medical Center73
- Gene6→24
- Genome7→24
- Transcriptome1→15
- Microbiome1→7
- Phenotype1→7
- Disease1→33
- Transcriptome1→13
- Cancer1→11
- Genome2→12
- Epigenetics1→7
- Disease1→23
- Clinical trial1→7
- Microbiome3→9
- Cancer1→7
- Biomarker1→7
Where bioinformatics is researched across Netherlands
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.